Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Clinical trial NCT00396279 · COMPLETED
Trial details
- NCT number
- NCT00396279
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-10
- Primary completion
- 2008-04-07
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.